CurrentEndo
Get Weekly

Topic · page 12 of 12

Lipids & metabolic liver disease

Lipid disorders and metabolic dysfunction-associated steatotic (fatty) liver disease, as published in the endocrine journals

Briefs 441–460 of 460 placed here, newest publication first

Briefs in Lipids & metabolic liver disease

Newest publication first

  1. Obesity (Silver Spring)

    Metabolic profiling of MRI ‐measured liver fat in the UK Biobank

    Cohort study

  2. JAMA Netw Open

    Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial

    Randomized controlled trial

  3. Cardiovasc Diabetol

    Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data

    Cohort study

  4. Obesity (Silver Spring)

    A prolonged fast improves overnight substrate oxidation without modulating hepatic glycogen in adults with and without nonalcoholic fatty liver: A randomized crossover trial

    Randomized controlled trial

  5. Pediatr Obes

    Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non‐alcoholic fatty liver disease

    Diagnostic or prognostic study

  6. J Clin Endocrinol Metab

    Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease

    Cross-sectional study

  7. Cardiovasc Diabetol

    Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease

    Cross-sectional study

  8. Lancet Diabetes Endocrinol

    Risks and burdens of incident dyslipidaemia in long COVID: a cohort study

    Cohort study

  9. Diabetes Obes Metab

    Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long‐term mortality in acute myocardial infarction

    Cohort study

  10. Lancet Diabetes Endocrinol

    Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

    Randomized controlled trial

  11. Diabetes Metab

    Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan

    Cohort study

  12. Diabetes Metab

    Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population

    Cohort study

  13. J Clin Endocrinol Metab

    Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without Mobilizing Cytoplasmic Lipid Droplets

    Mechanistic study

  14. J Clin Endocrinol Metab

    Effects of Statins on Fat Oxidation Improvements After Aerobic Exercise Training

    Cohort study

  15. Diabetes Obes Metab

    Associations of liver fat content with cardiometabolic phenotypes and outcomes in a multi‐ethnic population: Results from the Dallas Heart Study

    Cohort study

  16. Diabetes Metab

    Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis

    Cohort study

  17. Endocr Pract

    A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease

    Meta-analysis

  18. J Clin Endocrinol Metab

    A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia

    Research article

  19. J Clin Endocrinol Metab

    Nonalcoholic Fatty Liver Disease and Adverse Pregnancy Outcomes in Women With Normal Prepregnant Weight

    Cohort study

  20. Clin Endocrinol (Oxf)

    Association of serum uric acid with all‐cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease

    Cohort study

All 460 Briefs in ExploreShowing Briefs 441–460 of 460, newest first